Bbabo NET

News

Vaccines should provide good protection against the Omicron variant

Johannesburg, November 29 (bbabo.net News)
Existing vaccines should be very effective in preventing serious illness and hospitalization for the new version of Omidron on Kovid-19, said a leading South African immunologist, citations from Reuters. Salim Abdul Karim also said it was too early to say whether Omicron was causing more severe clinical symptoms than previous versions. However, he stressed that this option seems more contagious and is more likely to infect people with immunity from vaccination or previous illness. Therefore, it is expected to increase the number of cases in the country to 10,000 per day before the end of the week at 1858 on Sunday. "Based on what we know and how other anxiety options respond to vaccine immunity, we can expect to again see high efficacy against hospitalizations and serious illness, and that protection against vaccines is likely to remain strong. "- said at a press conference Prof. Abdul Karim, who was the chief consultant of the government in the first wave of Kovid-19. often infections. So even (the infection) escapes the antibodies, it is very difficult to escape the T cells, he explained.
The discovery of the option in South Africa has provoked a very strong reaction around the world and many countries have limited transport links with the country, imposing other restrictions.
The World Health Organization said today that the option poses a very high global risk of increasing the number of people infected, even if additional research is needed to assess its potential to escape immunity from vaccines and get sick.
South African doctors who cared for patients with the avian Omicron claim that for now it seems to cause mild symptoms - dry cough, fever, sweating. However, it is still too early for definite conclusions, because doctors can only comment on the condition of their patients. "" I still do not have enough data, "said Prof. Abdul Karim.



Vaccines should provide good protection against the Omicron variant